Director’s Corner 2018

Director’s Corner is a new experiment for the CBC website and will feature stories, opinions and other items of interest to the growing biomedical, translational research and entrepreneurial communities in Chicago (and beyond).


2018

October 16, 2018
DIRECTOR’S CORNER
True costs of drug discovery
By Jim Audia
▸ Read more


June 29, 2018
DIRECTOR’S CORNER
Changes in FDA’s Approach to Predictive Toxicology
By Jim Audia
▸ Read more


June 4, 2018
DIRECTOR’S CORNER
Modernization effort at FDA’s Center for Drug Evaluation and Research (CDER)
By Jim Audia
▸ Read more


May 22, 2018
DIRECTOR’S CORNER
Medicinal chemistry (or drug discovery more generally) is hard. Some guidance for making it possible.
By Jim Audia
▸ Read more


May 14, 2018
DIRECTOR’S CORNER
Precision Medicine ‘Of the people, for the people, by the people’?
By Jim Audia
▸ Read more


March 29, 2018
DIRECTOR’S CORNER
A rising tide: Chicago biomedical research institutions to receive increased NIH funding in 2018
By Jola Glotzer
▸ Read more


March 13, 2018
DIRECTOR’S CORNER
Connecting with my past and celebrating the chemistry of the future at the Lilly Grantee Symposium
By Jim Audia
▸ Read more


March 8, 2018
DIRECTOR’S CORNER
How not to do it? Mastering (or not) the hyperbole
By Jim Audia
▸ Read more


March 5, 2018
DIRECTOR’S CORNER
More recognition for Chicago, role of local universities in the startup community
By Jim Audia
▸ Read more


February 23, 2018
DIRECTOR’S CORNER
Evolving FDA guidance for developing early Alzheimer’s Disease therapeutics
By Jim Audia
▸ Read more


February 13, 2018
DIRECTOR’S CORNER
What do we mean by ‘discharging translational risk’?
By Jim Audia
▸ Read more


February 8, 2018
DIRECTOR’S CORNER
Analyzing the Past to Predict the Future of Pharmaceutical R&D
By Jim Audia
▸ Read more


February 7, 2018
DIRECTOR’S CORNER
Design Principles for Building an Entrepreneurial Ecosystem
By Jim Audia
▸ Read more